about
Transglutaminases in Dysbiosis As Potential Environmental Drivers of Autoimmunity.Differentiation of fibrotic liver tissue using laser-induced breakdown spectroscopy.Transglutaminase 2 in human diseases.Concepts for a therapeutic prolongation of nephrogenesis in preterm and low-birth-weight babies must correspond to structural-functional properties in the nephrogenic zone.The Candida albicans ENO1 gene encodes a transglutaminase involved in growth, cell division, morphogenesis and osmotic protection.A small molecule regulator of tissue transglutaminase conformation inhibits the malignant phenotype of cancer cells
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Transglutaminase inhibitors: a patent review.
@en
type
label
Transglutaminase inhibitors: a patent review.
@en
prefLabel
Transglutaminase inhibitors: a patent review.
@en
P2860
P1476
Transglutaminase inhibitors: a patent review.
@en
P2093
Jeffrey W Keillor
Kim Y P Apperley
P2860
P356
10.1517/13543776.2016.1115836
P407
P577
2015-11-11T00:00:00Z